Inosine and Sodium Chloride Injection

 Bioenergy is stored in the form of high-energy phosphate bonds in adenosine triphosphate (ATP). The synthesis of ATP primarily relies on ATP synthase within the mitochondria. ATP synthase utilizes the electrochemical potential generated by the mitochondrial respiratory chain as an energy source to phosphorylate ADP and synthesize ATP. Therefore, the metabolic process of energy synthesis is the oxidative phosphorylation process carried out by mitochondria. Maintaining the normal physiological function of mitochondria is essential for energy synthesis and metabolism. Based on the latest research in energy metabolism pharmacology and the practical needs of clinical medicine and research, the development of Adenosine Chloride Sodium Injection has brought new treatment approaches to healthcare professionals. It has unique efficacy in the rescue and rehabilitation treatment of cardiovascular and cerebrovascular diseases, protective treatment for various liver diseases, and nutritional support for cancer patients. Additionally, it is a new convenient intravenous infusion formulation that reduces the risk of infection, fully meeting the clinical needs for the treatment of various acute and chronic diseases.

Packaging： 60 bags per case

Specifications： 100ml: 0.6g adenosine and 0.9g sodium chloride

Shelf Life： 24 months

Approval Number： 国药准字H20030398

Indications： Coenzyme drug with the function of improving organism metabolism. Used as adjuvant therapy for leukopenia, thrombocytopenia, heart failure, angina pectoris, hepatitis, etc. Also used as adjuvant therapy for optic nerve atrophy and central retinitis.